This Booklet of Information,which includes the policiesand procedures of theA m e r i c a n B o a r d o fDermatology, supersedes allprevious publications of theBoard.

The Board reserves the rightto make changes in its fees,policies, and procedures atany time and will make everyeffort to give advance noticewhen such changes are made.

Copyright©2005 American Board ofDermatology, Inc. ®

The

AMERICAN BOARD

of

DERMATOLOGY, INC. ®

Incorporated 1932

A Founding Member Board - The American Board ofMedical Specialties (ABMS)

Antoinette F. Hood, M.D.Executive Director

The American Board of Dermatology, Inc. ®Henry Ford Health System

1 Ford PlaceDetroit, Michigan 48202-3450

Stephen B. Webster, M.D.Associate Executive Director

(313) 874-1088FAX: (313) 872-3221

E-mail address: abderm@hfhs.orgWebsite: www.abderm.org

January 1, 2005

THE AMERICAN BOARD OF DERMATOLOGY ®OFFICERS AND DIRECTORS

2005

PRESIDENTDavid R. Bickers, M.D., New York, NY

PRESIDENT-ELECTClifton R. White, Jr., M.D., Portland, OR

VICE PRESIDENTKim B. Yancey, M.D., Milwaukee, WI

Terry L. Barrett, M.D., Dallas, TX

Jean L. Bolognia, M.D., New Haven, CT

Robert T. Brodell, M.D., Warren, OH

Jeffrey P. Callen, M.D., Louisville, KY

Leonard M. Dzubow, M.D., Media, PA

Evan R. Farmer, M.D., Norfolk, VA

Ilona J. Frieden, M.D., San Francisco, CA

Thomas D. Horn, M.D., Little Rock, AR

Lela A. Lee, M.D., Denver, CO

Henry W. Lim, M.D., Detroit, MI

Randall K. Roenigk, M.D., Rochester, MN

Paul I. Schneiderman, M.D., Syosset, NY

Elaine C. Siegfried, M.D., St. Louis, MO

STAFF:EXECUTIVE DIRECTORAntoinette F. Hood, M.D.

ASSOCIATE EXECUTIVE DIRECTORStephen B. Webster, M.D.

EXECUTIVE CONSULTANTSHarry J. Hurley, M.D.John S. Strauss, M.D.

ADMINISTRATORMargaret M. Aguiar

ASSISTANT ADMINISTRATORJean Modaffare

STAFF ASSISTANTCynthia Campbell

2

EMERITUS DIRECTORS AND CONSULTANTSTO THE BOARD

Harold N. Cole, Sr., M.D. ..........................................1932-1940Howard Fox, M.D. .....................................................1932-1945C. Guy Lane, M.D. ....................................................1932-1946 (Secretary).............................................................1932-1943George M. MacKee, M.D. .........................................1932-1938William H. Mook, M.D................................................1932-1933Howard Morrow, M.D. ...............................................1932-1937Jay F. Schamberg, M.D. ...........................................1932-1933Arthur W. Stillians, M.D. ............................................1932-1940Frederick D. Weidman, M.D......................................1933-1950Charles C. Dennie, M.D. ...........................................1934-1945Paul O'Leary, M.D. ....................................................1938-1948J. Gardner Hopkins, M.D...........................................1939-1948Francis E. Senear, M.D.............................................1939-1951Henry E. Michelson, M.D. .........................................1941-1950J. Bedford Shelmire, Sr., M.D. ..................................1941-1949George M. Lewis, M.D. ............................................1944-1955 (Secretary-Treasurer)............................................1944-1952Anthony C. Cipollaro, M.D.........................................1946-1955 (Secretary-Treasurer)............................................……..1953Hiram E. Miller, M.D. .................................................1946-1947Nelson P. Anderson, M.D..........................................1947-1956Arthur C. Curtis, M.D.................................................1948-1957Donald M. Pillsbury, M.D...........................................1948-1953John H. Lamb, M.D. ..................................................1949-1958J. Lamar Callaway, M.D. ...........................................1950-1959Marcus. R. Caro, M.D. ..............................................1951-1960Francis W. Lynch, M.D..............................................1951-1960Beatrice M. Kesten, M.D. ..........................................1953-1962 (Secretary-Treasurer)............................................1954-1960Clinton W. Lane, M.D. ...............................................1955-1964Walter C. Lobitz, Jr., M.D..........................................1955-1964Maurice J. Costello, M.D...........................................1960-1963 (Secretary-Treasurer)............................................1961-1963J. Walter Wilson, M.D................................................1957-1966Louis A. Brunsting, Sr., M.D......................................1957-1966Edward P. Cawley, M.D. ...........................................1958-1967Wiley M. Sams, M.D..................................................1959-1968Walter B. Shelley, M.D., Ph.D...................................1960-1969Clarence S. Livingood, M.D. .....................................1962-1968 (Secretary-Treasurer)............................................1964-1968 (Exec. Secretary/Exec. Director) ..........................1969-1992 (Executive Consultant) ..........................................1993-1998Rudolf L. Baer, M.D...................................................1963-1972Ray O. Noojin, M.D. ..................................................1964-1973Rees B. Rees, M.D. ..................................................1964-1974Harry L. Arnold, Jr., M.D. ..........................................1967-1976E. Richard Harrell, Jr., M.D. ......................................1968-1977John R. Haserick, M.D. .............................................1968-1977Robert W. Goltz, M.D. ...............................................1969-1978 (Asst. Executive Director) .....................................1980-1987J. Fredric Mullins, M.D. .............................................1969-1978Clayton E. Wheeler, Jr., M.D. ...................................1970-1979Alfred W. Kopf, M.D. .................................................1972-1981Richard B. Stoughton, M.D. ......................................1973-1982J. Graham Smith, Jr., M.D. .......................................1974-1984

3

EMERITUS DIRECTORS AND CONSULTANTSTO THE BOARD (continued)

John H. Epstein, M.D. ...............................................1974-1984Frederick A.J. Kingery, M.D. .....................................1974-1984Harry J. Hurley, M.D..................................................1974-1984 (Asst. Executive Director) .....................................1984-1988 (Assoc. Executive Director)...................................1989-1992 (Executive Director)...............................................1993-2000 (Executive Consultant) ..........................................2001-John M. Knox, M.D....................................................1976-1985G. Thomas Jansen, M.D. ..........................................1977-1987James H. Graham, M.D. ...........................................1977-1987Peyton E. Weary, M.D...............................................1978-1988Richard L. Dobson, M.D............................................1978-1989Peter J. Lynch, M.D...................................................1984-1989Harold O. Perry, M.D.................................................1979-1990Samuel L. Moschella, M.D. .......................................1984-1990William A. Caro, M.D.................................................1981-1991John S. Strauss, M.D. ...............................................1982-1992 (Assoc. Executive Director)...................................1993-2000 (Executive Consultant) ..........................................2001-Edgar B. Smith, M.D. ................................................1991-1993Irwin M. Freedberg, M.D. ..........................................1984-1994Edward A. Krull, M.D.................................................1984-1994Mark Allen Everett, M.D. ...........................................1986-1995Stephen I. Katz, M.D., Ph.D......................................1989-1995Barbara A. Gilchrest, M.D. ........................................1988-1996Loren E. Golitz, M.D..................................................1988-1996Lowell A. Goldsmith, M.D..........................................1993-1996Ronald J. Barr, M.D...................................................1989-1998Anne W. Lucky, M.D. ................................................1989-1998W.P. Daniel Su, M.D. ................................................1997-1998John C. Maize, M.D...................................................1991-1999Rex A. Amonette, M.D. .............................................1992-1999Antoinette F. Hood, M.D............................................1992-2000 (Executive Director)..............................................2001-Stephen B. Webster, M.D. ........................................1992-2000 (Assoc. Executive Director)..................................2001-Lee T. Nesbitt, Jr., M.D. ............................................1993-2001Kenneth E. Greer, M.D..............................................1994-2002Diane R. Baker, M.D. ................................................1995-2003Darrell S. Rigel, M.D. ................................................1995-2003Paul R. Bergstresser, M.D. .......................................1996-2004Ronald P. Rapini, M.D...............................................1996-2004

4

HISTORICAL

The American Board of Dermatology andSyphilology was incorporated in 1932 to elevate andmaintain the standards of this specialty. Itsfoundation stemmed from a growing awareness thatspecialization in medicine had to be based onadequate training, knowledge, and experience. In1955, the official name of the Board was changed tothe American Board of Dermatology, Inc.®

The original sponsoring organizations were theAmerican Dermatological Association and theSection on Dermatology and Syphilology of theAmerican Medical Association. In 1939, theAmerican Academy of Dermatology became thethird sponsoring organization. The Board wasoriginally composed of nine Directors and hasgradually expanded to the present size of 16. TheBoard is incorporated to function independently inregard to rulings, examinations and finances.

The American Board of Dermatology (1932) wasone of the four original sponsoring Boards (with theAmerican Boards of Ophthalmology [1917],Otolaryngology [1924], and Obstetrics andGynecology [1930]) of the Advisory Board ofMedical Specialties, the predecessor of theAmerican Board of Medical Specialties. TheAmerican Board of Dermatology is one of the 24member Boards of the American Board of MedicalSpecialties.

The history of the American Board ofDermatology has been described in an articleentitled "History of the American Board ofDermatology, Inc.® 1932-1982" by Clarence S.Livingood, M.D. which was published in the Journalof the American Academy of Dermatology,1982;7:821. Reprints are available from the office ofthe Board or you can view the article on our websiteat www.abderm.org.

5

OTHER PUBLICATIONS

The Program Requirements for ResidencyEducation in Dermatology, which is the officialpublication of the Residency Review Committee forDermatology and is approved by the AccreditationCouncil for Graduate Medical Education (ACGME),is published annually in the AMA Graduate MedicalEducation Directory. Copies of the ProgramRequirements for Residency Education inDermatology can be obtained from the office of theAmerican Board of Dermatology or from the ACGMEwebsite at www.acgme.org.

Copies of the Program Requirements forResidency Education in Dermatopathology arepublished in the AMA Graduate Medical EducationDirectory) and are also available on the ACGMEwebsite (www.acgme.org). The programrequirements for residency education in Clinical andLaboratory Dermatological Immunology andPediatric Dermatology are available on the ABDwebsite at www.abderm.org.

PURPOSES AND FUNCTIONS OF THE

BOARD

The American Board of Dermatology is avoluntary, non-profit, private, autonomousorganization formed for the primary purpose ofprotecting the public interest by establishing andmaintaining high standards of training, educationand qualifications of physicians rendering care indermatology. The objective of all of its activities is toprovide assurance that a diplomate of the Boardpossesses the knowledge, skills, and competenciesessential for the provision of superior, specializedcare to patients with cutaneous diseases.

During the first 23 years of its existence, theBoard was responsible for the evaluation ofresidency training programs in dermatology. In1955, this responsibility was assumed by theResidency Review Committee for Dermatology,a body established by the American Board of

6

and the Council on Medical Education of the AMA.Composed of four representatives from theAmerican Board of Dermatology and fourrepresentatives from the American MedicalAssociation and acting with authority delegated to itby the Accreditation Council for Graduate MedicalEducation (ACGME), the Residency ReviewCommittee for Dermatology meets semi-annually toreview and accredit training programs. Informationconcerning accredited dermatology residencytraining programs may be found in the AMAGraduate Medical Education Directory (which ispublished annually by the AMA under the authorityof the ACGME), or from the ACGME website atwww.acgme.org. Residency training in dermatologyin Canada must be taken at institutions approved forsuch training by the Royal College of Physicians andSurgeons of Canada.

The Board carries out its purposes by:

1. establishing requirements for post-doctoral training inDermatology, Dermatopathology (in concert with theAmerican Board of Pathology), Clinical and LaboratoryDermatological Immunology, Pediatric Dermatology, andProcedural Dermatology.

2. participating, through the Residency Review Committee forDermatology, in the accreditation of Dermatology,Dermatopathology, and Procedural Dermatology residencytraining programs in hospitals and institutions providingsuch training.

3. participating in the assessment and approval of fellowshipsin Clinical and Laboratory Dermatological Immunology, andPediatric Dermatology.

4. monitoring the training of each candidate as documented inannual progress reports submitted by directors of residencyand fellowship training programs.

5. creating and supplying to program directors an annual in-training examination used to monitor the progress oftrainees.

6. assessing the credentials of candidates who applyvoluntarily for certification in Dermatology or subspecialtycertification in Dermatopathology, Clinical and LaboratoryDermatological Immunology, or Pediatric Dermatology.

7. creating and conducting comprehensive examinations todetermine the competence of physicians who meet theeligibility requirements for certification in Dermatology orsubspecialty certification in Dermatopathology (in concertwith the American Board of Pathology), Clinical andLaboratory Dermatological Immunology, or PediatricDermatology.

7

8. issuing an appropriate certificate to those dermatologistswho meet the requirements of the Board and satisfactorilycomplete the certifying examination in Dermatology, andsubspecialty certification examinations in Dermato-pathology (in concert with the American Board ofPathology), Clinical and Laboratory DermatologicalImmunology, and Pediatric Dermatology.

9. developing and conducting an appropriate program ofevaluation for the voluntary recertification of physicians whohave been issued time-limited certificates in Dermatology,and for diplomates with lifetime certification who elect topursue the voluntary recertification process.

It is not the purpose of the Board to definerequirements for membership on hospital staffs, orto gain special recognition or privileges for itsdiplomates in the practice of dermatology. It doesnot define who may or may not practicedermatology. It is neither a source of censure noran entity for the resolution of ethical or medico-legalproblems. However, the Board endorses the ethicalprinciples enunciated in the Manual on Ethics inMedical Practice of the American Academy ofDermatology and recommends adherence to theseprinciples in dermatologic education, research andclinical practice.

GENERAL INFORMATION

This booklet has been prepared to supplyinformation concerning requirements for certificationby the American Board of Dermatology.

All queries concerning the requirements forcertification or other matters with which the Board isconcerned, should be directed to the ExecutiveDirector of the Board. In view of the nature andsignificance of the decisions made, communicationsbetween the Executive Director and the candidatesshould be in writing.

It is the responsibility of directors of dermatologytraining programs to make certain that theirresidents file a Preliminary Registration Form withthe office of the Board by August 1 or within 30 daysof the start of training. The filing of the PreliminaryRegistration Form will establish the identity andstatus of the candidate and will begin his or her

8

permanent file. Evaluation of progress in thetraining of each candidate is made possible by theannual reports submitted by the director of thetraining program to the Board. For dermatologyresidents, first and second year evaluation reportsare due in the Board office by August 1. For thirdyear residents, evaluation reports must beforwarded to the Board office no later than May 15.Included in the third year report is a verification bythe program director of the candidate's satisfactorycompletion of the residency and his or herpreparedness, as a result of this training andexperience, to take the certifying examination.Program directors are also required to submit theTabulation of Experience in Dermatologic Surgeryforms for each resident in his or her final year oftraining. (This is a compilation of experience for allthree years of residency training.)

The American Board of Dermatology, inconjunction with the American Board of Pathology,has established a mechanism for subspecialtycertification in Dermatopathology (see pages 27-29).Mechanisms for subspecialty certification have alsobeen established in Clinical and LaboratoryDermatological Immunology (pages 31-32), andPediatric Dermatology (pages 32-34).

It is the responsibility of directors of fellowshipsin Dermatopathology, Clinical and LaboratoryDermatological Immunology, and PediatricDermatology to make certain that their trainees file apreliminary registration form by August 1 or within30 days of the start of training. For additionalinformation concerning any of these subspecialtycertification examinations, write to the ExecutiveDirector of the American Board of Dermatology.

9

REQUIREMENTS FOR ELIGIBILITY

TO TAKE THE CERTIFYING EXAMINATION

IN DERMATOLOGY

Each applicant must satisfy the followingrequirements before he or she is eligible to take thecertifying examination of the Board.

A. General Qualifications (1) The candidate must have graduated from amedical school in the United States accredited bythe Liaison Committee for Medical Education(LCME), an accredited medical school in Canada,an accredited osteopathic school in the UnitedStates, or if a graduate of a foreign medical school,must possess the standard certificate of theEducational Commission for Foreign MedicalGraduates (ECFMG). If, however, the foreignmedical school graduate is in training in anaccredited program in Canada, the Board willrecognize the certificate of the Medical Council ofCanada.

(2) The candidate must hold a currently valid, fulland unrestricted license to practice medicine orosteopathy in the state or province of his or herresidence in either the United States or Canada.The candidate may be denied certification if his orher license has been revoked, suspended,restricted, or surrendered in any jurisdiction – or ifthe candidate is subject to adverse licensureproceedings.

(3) The candidate must not have engaged inconduct which, in the judgment of the Board, (i)reflects unethical activity relating to the practice ofmedicine, or (ii) casts significant doubt on the abilityof the candidate to practice dermatology in the bestinterests of patients.

B. Residency Training Requirements (1) Candidates for certification by the AmericanBoard of Dermatology are required to have a total offour years of postgraduate training as describedbelow in Sections (a) and (b).

a) The first year (PGY 1) must consist of 12months of clinical training in one of the following

10

types of broad-based programs in the United Statesaccredited by the Accreditation Council for GraduateMedical Education (ACGME) or a similar program inCanada accredited by the Royal College ofPhysicians and Surgeons of Canada: a transitionalyear (formerly called flexible first postgraduate year),or a first year residency in emergency medicine,family practice, general surgery, internal medicine,obstetrics & gynecology, or pediatrics.

b) Three years of full-time training as aresident in a dermatology residency trainingprogram in the United States accredited by theAccreditation Council for Graduate MedicalEducation (ACGME) or three years of full-timetraining as a resident in a dermatology residencytraining program in Canada accredited by the RoyalCollege of Physicians and Surgeons of Canada.Accreditation of dermatology training programs inthe United States is the responsibility of theResidency Review Committee for Dermatologyacting with authority delegated to it by the ACGME(accredited dermatology residency trainingprograms and clinical programs for firstpostgraduate year credit are listed in the AMAGraduate Medical Education Directory and also onthe ACGME website at www.acgme.org).

c) The resident's time throughout each year(PGY 2 – PGY 4) must be related to direct care ofoutpatients and inpatients (to include clinicalconferences and didactic lectures related to patientcare, consultations, inpatient rounds, dermatologicsurgery, dermatopathology, and other subspecialtyrotations concerning dermatology). Dermato-pathology, microbiology, and other basic sciencelectures, seminars, and conferences are essentialcomponents of the resident's training (see theProgram Requirements for Residency Training inDermatology referred to on page 6 of thisBooklet).

The Board also emphasizes the importance ofbasic science and clinical investigation in theeducational experience of trainees. Accordingly, allresidents should participate in basic science and/orclinical research during their training. Individualprograms may permit elective time, not to

11

exceed 3 months per three-year period. Residencytraining requirements for individuals enrolled in anInvestigative/Academic Training Track, arediscussed under (d) below.

d) For those candidates whose career plansinvolve a primary commitment to investigative oracademic dermatology, an Investigative/AcademicTraining Track, which must assure adequate clinicaleducation and experience in accordance with thegeneral requirements described above, may also beacceptable. Program directors should contact theExecutive Director of the Board for informationconcerning this special track, such as eligibilityrequirements and when and how to submitapplications to the Board. The essential elements ofsuch training tracks are as follows:

1) Training experiences for individuals in theInvestigative/Academic Training Track must becandidate-specific (i.e., not a program-specificpathway).

2) The first year (PGY 2) of this track must be100% clinical in character.

3) Investigative or academic experience can beintegrated with the required clinical trainingduring the second (PGY 3), third (PGY 4) and/orfourth (PGY 5) years. In this track (i.e., theInvestigative/Academic Training Track),residents must satisfy a requirementfor 225% direct patient care time (as defined by100% clinical training in the first [PGY 2] yearand the balance of 125% clinical trainingapportioned over the second [PGY 3],third [PGY 4], and/or fourth [PGY 5] years of thistrack). In addition, the Investigative/AcademicTrack must include the equivalent of a one-halfday clinic per week each year until the 225%requirement is met. Continuity of patient careshould be stressed as much as possible in thisclinic experience. Rotations on the consultationservice, for a period comparable to the timesimilarly scheduled for general dermatologyresidents, may be substituted for the clinic timeduring the special training track years of theresidency.

12

4) Requests for approval of this Investigative/Academic training track must be submittedprospectively, at least four (4) months prior tothe beginning of such training. This will be on orbefore March 1 of the PGY 2 year for a specialtrack beginning on July 1 of the PGY 3 year, orlater if special track training is to begin later.Requests earlier than January 1 of the PGY 2year will not be considered because theprogram director must have had an opportunityto judge the clinical potential of the trainee.

The request for consideration of thisInvestigative/Academic Training Track must includedetails of the scheduled program and timecommitments during the entire training period forthese candidates. It is incumbent upon programdirectors to select candidates for this special trainingtrack whose skills and learning capabilities permitthe acquisition of clinical competence as well as theexecution of their investigative or academicresponsibilities. Moreover, the program directormust monitor the training of these residentsthroughout their residency and must validate theirclinical experience at the completion of theirresidencies.

(2) A Preliminary Registration Form must befiled by the candidate and signed by his/hertraining director shortly after the resident beginsresidency training in dermatology (i.e., byAugust 1 or within 30 days of the start oftraining).

(3) It is mandatory that the training directorsubmit a Yearly Report Form for each resident tothe Board office by August 1 after completion ofthe first and second year of training and by May15 for residents who will complete their thirdyear of training on June 30. Tabulation ofExperience in Dermatologic Surgery forms arerequired from residents in their final year of training.(This is a compilation of experience for all threeyears of training.) In order for a candidate to takethe certifying examination, the training director mustcertify that the residency training was completed in asatisfactory manner.

13

(4) Training must be completed within fiveyears after the beginning of dermatology residency,except when military service or other compellingcircumstances intervene.

(5) It is the responsibility of the training directorto determine if a resident has satisfactorilycompleted the required 3 years of dermatologytraining and is therefore eligible to apply for thecertifying examination of the American Board ofDermatology (see Guidelines below).

GUIDELINES FOR DETERMINING

ADEQUACY OF CLINICAL TRAINING

The following guidelines are designed to assistprogram directors in their determination of theadequacy of the clinical training of residents and toassure satisfaction of the eligibility requirements forcertification by the American Board of Dermatology.Of special concern are those residents registered forthe Investigative/Academic Training Track (pages 12& 13) or those residents whose training experiencediffers from the standard 36 months of full-timeclinical training, as approved for each program bythe Residency Review Committee of the ACGME:

a) In general, high priority should be given tocompleting 36 continuous months of full-timedermatology training. For most residents, thiswill consist of full-time clinical training; forresidents with a primary commitment toinvestigative or academic dermatology, this maybe a special training track as defined on page12.

b) Any departure from (a), as required for examplefor a medical leave of absence, should bedocumented and fully justified in the residentevaluation forms filed annually with the Board bythe training program director.

c) An absence exceeding six weeks in any oneacademic year or a total of 14 weeks over threeyears, including vacation, should be approvedonly under truly exceptional circumstances. Inaddition, any resident approved to sit for the

14

certifying examination despite such an absenceshould have completed each year of training inan above average or excellent manner.

d) Any resident who will have been absent morethan six weeks in one year or 14 weeks overthree years and whose performance has notbeen uniformly above average or excellentthroughout residency training should be requiredto complete an additional period of training atleast equal in length to the total period ofabsence in excess of routinely provided totalvacation time. If the program directoranticipates that this additional training will becompleted in a satisfactory manner beforeSeptember 1, the Director may approve theresident to sit for the certifying examination thatyear, just as if training had been completedby the first of July.

IN-TRAINING EXAMINATION (ITE)

An in-training examination is administeredannually online in April (usually the third Thursday inApril) to dermatology residents. The intent of theITE is to identify knowledge-based strengths andweaknesses in both the training program and theresidents in a non-punitive manner. Althoughparticipation in the in-training examination programis voluntary, most training programs participateannually because both training directors andresidents find the ITE to be a meaningfuleducational experience. The format of the ITEincludes only the types of questions that appear onthe certifying examination: i.e., one best answer,matching, and identification of images.

The examination is a 4-hour proctored computer-based examination. Residents take the examinationas a group in their individual training programs.Contact the Board office for the optimal computerrequirements.

In 2005, the date of the In-Training Exam-ination is Thursday, April 21, 2005. Applicationsare mailed to training programs in December and

15

the deadline for returning the applications to theBoard office is February 1. Results will be sent toindividual residents as well as to training directors.

Test Committee for In-Training ExaminationLela A. Lee, M.D., ChairmanDavid R. Bickers, M.D.Jean L. Bolognia, M.D.Robert T. Brodell, M.D.Ilona J. Frieden, M.D.Paul I. Schneiderman, M.D.Christopher J. Arpey, M.D.*Sylvia L. Brice, M.D.*Sarah L. Chamlin, M.D.*Elizabeth M. Dugan, M.D.*Eric W. Kraus, M.D.*Stephen B. Webster, M.D. (Staff)

*Non-ABD Director members of the test committee.

REGISTRATION FOR THE EXAMINATION OFTHE BOARD

Candidates who have completed the trainingrequirements as outlined above are eligible to applyfor examination by the Board. Candidates mayrequest an Application for Certification Form fromthe office of the Executive Director of the Board.However, for those candidates who arecompleting their residency training, applicationforms will be sent to the program directors fordistribution to each candidate. The completedapplication must be filed with the Board office beforeMarch 1 of the year in which the candidate plans totake the examination. Physicians who completetheir residency training in dermatology by July 1 areeligible to apply to take the examination in August ofthat year. Under the special conditions described onpage 14 (Guidelines for Determining Adequacy ofClinical Training), candidates completing additional(make-up) training before September 1 may also beeligible to apply to take the certifying examination. Itis emphasized that it is the candidate's responsibilityto send a completed application form to the Board ifhe or she plans to take the certifying examination ofthe Board.

A candidate is not considered an "active"candidate until his or her application has beenreceived and approved by the Board. This approvalincludes a review of the application and annual

16

evaluation reports from the candidate's trainingdirector. After the application is approved, thecandidate is required to take the examination withintwo years. Candidates who do not exercise theexamination privilege within two years of the datethat they are declared eligible will be required to filea new application and have their eligibility forexamination reviewed by the RequirementsCommittee. If the reapplication is approved by theBoard, the candidate is again eligible to take theexamination for another two-year period. It shouldbe noted that candidates who have had an extendedlapse in clinical practice or in other activities relatedto dermatology may be required to submit evidenceof their continued involvement with the specialty ofdermatology.

The Board does not use the term “Board-eligible" in corresponding with directors of hospitalsor others who send inquiries to the Board office. Onwritten request by a candidate and payment of a fee(see Fees, page 36), the Board will send to thecandidate a letter stating his or her status with theBoard at any given time.

COMBINED TRAINING IN DERMATOLOGY

AND INTERNAL MEDICINE

The American Board of Dermatology and theAmerican Board of Internal Medicine have conjointlyapproved the Guidelines for Combined Training inDermatology and Internal Medicine, copies of whichmay be obtained from the Board office ordownloaded from the ABD website atwww.abderm.org, under Residency Training.

Program Directors interested in establishing acombined training program should write to the Boardoffice for an application form, which must bereviewed and approved by the American Board ofDermatology and the American Board of InternalMedicine. The application form may also bedownloaded from the ABD website atwww.abderm.org, under Residency Training.

17

COMBINED TRAINING IN DERMATOLOGY

AND PEDIATRICS

The American Board of Dermatology and theAmerican Board of Pediatrics have conjointlyapproved the Guidelines for Combined Training inDermatology and Pediatrics, copies of which may beobtained from the Board office or downloaded fromthe ABD website at www.abderm.org, underResidency Training.

Program Directors interested in establishing acombined training program should write to the Boardoffice for an application form, which must bereviewed and approved by the American Board ofDermatology and the American Board of Pediatrics.The application form may also be downloaded fromthe ABD website at www.abderm.org, underResidency Training.

BOARD EXAMINATION

The certifying examination in dermatology,which is administered over a period of two days,includes the following:

1. Comprehensive Multiple Choice Examination inDermatology (Part I): This is a three-hourcomprehensive examination and was formerlyreferred to as the Written examination. It tests thecandidate's knowledge of the basic science andclinical aspects of dermatology, including all therelated disciplines. Among the topics included inthis part of the examination are clinical dermatology,pediatric dermatology, preventive dermatology,entomology, epidemiology, dermatopathology,cutaneous allergy and immunology, dermatologicsurgery, cutaneous oncology, sexually transmitteddiseases, internal medicine as it pertains todermatology, medical ethics, photobiology andcutaneous microbiology as well as anatomy,physiology, biochemistry, molecular biology,radiation physics, radiation therapy, physicaltherapy, pharmacology, genetics, and electronmicroscopy as related to dermatology.

18

Considerable emphasis is placed on comprehensiveknowledge of the literature.

2. Examination in Clinical and LaboratoryDermatology (Part IIA): Projected images areutilized in this part of the examination. Candidatesmust answer multiple choice type questions aboutthe projected pictorial material, which is drawn fromall areas of clinical and laboratory dermatology.Examples of the types of images used includephotographs of patients, diagrams and illustrativedrawings and pictures of histopathologic sections,fungal cultures, culture mounts, bacterial cultures,Tzanck preparations, skin scrapings and smears,roentgenograms, histochemical and fluorescentphoto-micrographs, electron micrographs, darkfieldmicrographs and drawings or photographs oforganisms, including viruses, rickettsiae, bacteriaand parasites that affect the skin.

3. Examination in Dermatologic Surgery (Part IIB):Projected images are utilized in this part of theexamination. Candidates must answer multiplechoice type questions about the projected pictorialmaterial covering dermatologic surgical areasincluding, but not limited to, Mohs micrographicsurgery, hair transplantation, dermabrasion,sclerotherapy, liposuction, chemical peels, tissueaugmentation, and anatomy as it relates todermatologic surgery.

4. Examination in Dermatopathology (Part IIC): Inthis section, candidates are questioned onhistopathologic slides that they examinemicroscopically on microscopes provided by theBoard. This section of the examinationencompasses the entire spectrum ofdermatopathology.

For the purposes of scoring, the Part IIA andPart IIB examinations are combined with the Part IICexamination, and candidates must pass thiscombined Part II examination as well as the Part Iexamination in order to be certified. If a candidatefails either the Part I or the Part II Examination,only the failed component must be repeated.

19

Upon completion of the certifying examination,candidates will receive a letter notifying themwhether they passed or failed. A pass/failnotification letter will also be sent to the candidate’straining director.

The examination is given annually over atwo-day period involving a total of approximately tenhours. In 2005, it will be held on August 14 and15 at the Crowne Plaza Chicago O'Hare (5440 N.River Road, Rosemont, Illinois) which is in theO'Hare Airport area of Chicago. In 2006, it willbe held on August 13 and 14 at the Crowne PlazaChicago O’Hare in Rosemont, Illinois.

RE-EXAMINATION

With their initial examination application,candidates have a two-year period during whichthey may take the examination or any necessary re-examination on either a failed part or both parts ofthe examination. For a re-examination, candidatesmust notify the Board office by March 1 of the yearthey plan to retake the examination. If a candidatehas not passed or does not take the examinationduring this two-year period, he/she must re-applyand complete the necessary forms, after whichhe/she will have another two-year period of eligibilityduring which to take the examination or re-examination. For further information concerning thisas well as the appropriate fee (see Fees, pages 36-37) required, contact the Board office.

CANDIDATES WITH DISABILITIES

The American Board of Dermatology supportsthe intent of the Americans with Disabilities Act(ADA) and, therefore, will provide or allow the use ofnecessary auxiliary aids, services or testingconditions that do not fundamentally alter themeasurement of the skills or knowledge the Boardassessment program is intended to test. In order toimplement this policy, notification of the needfor special testing circumstances must besubmitted to the American Board ofDermatology by a candidate for certification at

20

the time that he/she submits the application forany of the Board's certifying examinations. Thisdeadline (March 1) is necessary in order to allowthe Board to request the necessarydocumentation, to review the records and toverify the disability, if necessary. In addition,since this policy also applies to the in-trainingexamination, which is under the jurisdiction of theAmerican Board of Dermatology, appropriateadvance notification of the need for special testingcircumstances must be provided when theapplication for the in-training examination issubmitted by the department.

Upon receipt of such request, the AmericanBoard of Dermatology will initiate the appropriateprocedural steps, but it should be understood thatall special arrangements must be made andagreed upon in advance. Special arrangementscannot be made at the time the examination isgiven. Therefore, early notification of the need forspecial testing circumstances is encouraged.

CHEMICAL DEPENDENCY OR

SUBSTANCE ABUSE

A candidate with chemical dependency orsubstance abuse will not be permitted to take theexamination unless he/she can submit evidence,which must be verifiable, that the disorder is beingtreated and is under control. Individuals with suchproblems or a history thereof must provide thenecessary documentation at the time of applicationto take the examination. A confirmatory letter from alicensed physician within one month of theexamination stating that the disorder no longerexists or is currently controlled is also necessary.

CERTIFICATION

After meeting the above requirements andpassing the examination, the candidate will beawarded a certificate which acknowledges that he orshe has completed the required course of graduatestudy and clinical training, has met other specific

21

standards and qualifications, and has passed theexamination conducted by the Board. Thecandidate is then referred to as a Diplomate of TheAmerican Board of Dermatology, Inc.® The namesof Diplomates of the Board appear in The OfficialABMS Directory of Board Certified MedicalSpecialists, published by Marquis Who's Who incooperation with the American Board of MedicalSpecialties. The certificate is issued for a 10-yearperiod. Renewal is subject to completion ofMaintenance of Certification requirements.

Each certificate is subject to revocation orsuspension in the event that (a) the diplomate wasnot eligible to receive the certificate, whether or notthe facts concerning ineligibility were known to theBoard when the certificate was issued; (b) thediplomate has made any material misrepresentationor omission in the application for certification or inany other statement to the Board or has failed intimely fashion to supplement any response to anyquestion on any application for certification orrecertification with respect to criminal conduct, lossor suspension of a medical license, medical staffprivileges, or medical society membership; (c) thediplomate is convicted of, or pleads nolo contendereto a crime, which in the judgment of the Boardrelates to the practice of medicine; (d) the diplomateis found to have engaged in conduct which, in thejudgment of the Board, (i) reflects unethical activityrelating to the practice of medicine, or (ii) castssignificant doubt on the ability of the diplomate topractice medicine in the best interests of patients; or(e) the diplomate is found by the Board to have (i)engaged in irregular behavior in connection with theexamination, (ii) had a license to practice medicinerevoked or suspended, (iii) been expelled from amedical society for reasons other than non-paymentof dues or failure to attend meetings, (iv) has hadmedical staff privileges revoked or suspended forreasons relating to the practice of medicine, (v)taken other action reasonably deemed by the Boardto be inconsistent with diplomate status, or (vi)willfully and materially violated any rule or policy ofthe Board.

22

REVIEW OF ADVERSE DECISIONS

The American Board of Dermatology recognizesa candidate's right of appeal following an adverseaction at any stage of the certification process.Within the residency program, trainees must beaccorded due process in compliance with provisionsestablished by the parent institution and asstipulated in the Essentials of AccreditedResidencies in Graduate Medical Education,(effective July 1, 1992) of the Accreditation Councilfor Graduate Medical Education.

Any candidate for certification (primary specialtyor subspecialty) or recertification shall be givenprompt written notice of any adverse decision by theBoard. Such notice shall briefly state the reason forthe adverse decision. It shall advise whether or notthe candidate has a right to appeal the decision andshall include a copy of this document.

A candidate found to have engaged in cheatingor other irregular behavior in connection with anexamination may appeal the Board’s finding, anyconsequent invalidation of the candidate’sexamination and any disbarment from futureexaminations. Such appeal must be received in theBoard office within 30 days of mailing the notificationof the finding by the Board.

A. APPEALABLE DECISIONS1. Request for Appeal Any physician (a) whose credentials for eligibilityto take an ABD examination have not beenapproved, or (b) who has been denied certificationfor a reason other than receipt of a failing grade onthe examination, or (c) whose certification orrecertification has been revoked, or (d) whoseapplication for reinstatement has been denied, shallhave a right to appeal the adverse decision bysubmitting a written request for appeal incompliance with this policy on Review of AdverseDecisions. Such request must contain a concisestatement of why the physician believes that theadverse decision was improper, must include anysupporting material that the physician wishes tohave considered, and must be received in the ABD

23

office within 30 days after the date of the Board’snotice of an adverse decision. The request mayalso include a request for a hearing. If a properrequest for appeal is not received within 30 days,the adverse decision shall constitute the finaldecision of the Board.

2. Review by Appeals Committee Each proper and timely request for appeal will bereviewed by an Appeals Committee consisting ofthree individuals appointed by the President. Nomember of the Appeals Committee shall haveparticipated in the adverse decision under reviewunless that decision was made by the full Board ofDirectors. The Appeals Committee, after reviewingthe request for appeal, shall either (a) affirm,reverse, or modify the adverse decision or (b) granta hearing if one has been requested and theCommittee determines that a hearing might beuseful.

If the Appeals Committee determines that ahearing might be useful, it shall schedule a hearingwithin 60 days after that determination. Not lessthan 30 days prior to the scheduled date of thehearing, the Appeals Committee shall notify thephysician in writing of the date, time, and place ofthe hearing. The Appeals Committee, at its solediscretion, may determine whether legal counsel forthe physician may be present at the hearing and theextent to which such counsel may participate.

The physician’s written intent to appear at thehearing must be received in the Office of the Boardnot later than 14 days before the scheduled date ofthe hearing. A physician who chooses to appearshall be given the opportunity to make a statementsummarizing his/her position. The AppealsCommittee shall not be bound by technical rules ofevidence usually employed in legal proceedings, butmay consider any evidence it deems appropriate. Arecord of the proceedings shall be kept. A copy ofthe hearing record shall be made available to thephysician upon payment of the cost of reproduction.All expenses incurred by the physician in connectionwith the hearing shall be borne by the physician.

24

Following the hearing, the Appeals Committeeshall determine whether to affirm, reverse, or modifythe adverse decision. The physician shall bepromptly notified in writing of the action of theAppeals Committee and the reason for the action.The Committee’s action in affirming, reversing, ormodifying the adverse decision shall be subject onlyto ratification by the Board of Directors.

3. Review by the Board of Directors The action of the Appeals Committee shall bereviewed no later than the next regularly scheduledmeeting of the Board of Directors. The Board ofDirectors shall ratify the action of the AppealsCommittee unless it finds that action to have beenarbitrary, unreasonable, or not sustained by therecord. The physician shall be promptly notified ofthe Board’s decision. The decision of the Board ofDirectors shall constitute the final action of theBoard on the matter.

B. NON-APPEALABLE DECISIONS1. Decisions by Residency Program or ProgramDirector Decisions by a physician’s Residency Program,Program Director, or sponsoring institution regardingcredit for training or any other matter shall not beappealable to the Board. Any disagreement by aphysician with such decisions should becommunicated to the Residency Program, ProgramDirector, or sponsoring institution. The Board willnot second-guess judgments of these entities.However, the physician may contact the Board todetermine what further steps, if any, may beavailable.

2. Decisions Based on Failure of the CertifyingExamination Adverse decisions based on a physician’s receiptof a failing grade on an ABD examination shall notbe appealable. Instead, the physician may, within30 days after the mailing of the examination results,request rescoring of the examination by hand. Suchrequest must be accompanied by payment of a feeof $35. Upon receipt of a proper and timely requestfor rescoring, the Board shall have the examinationrescored by hand. It shall communicate therescored results to the physician promptly afterreceiving those results.

25

REAPPLICATION AFTER REVOCATION OF

CERTIFICATION OR RECERTIFICATION

A physician whose certification or recertificationhas been revoked may apply for reinstatement as aDiplomate when the physician believes that thecircumstances underlying the Board’s action havebeen satisfactorily resolved. The physician shallapply by providing a written statement setting forthin detail the changes in circumstances. The Boardshall consider such statement and determinewhether to reinstate the physician’s certification orrecertification. The physician shall be promptlynotified of the Board’s decision.

TEST COMMITTEES

The American Board of Dermatology hasestablished Test Committees for the ComprehensiveMultiple Choice Examination in Dermatology (Part I),the Examination in Clinical and LaboratoryDermatology (Part IIA&B), and the Examination inDermatopathology (Part IIC). Members of theseTest Committees include Directors of the AmericanBoard of Dermatology and other physicians who arenot Directors of the Board.

Test Committee for Comprehensive Multiple ChoiceExamination in Dermatology (Part I)

Thomas D. Horn, M.D., ChairmanJean L. Bolognia, M.D., Vice ChairmanDavid R. Bickers, M.D.Evan R. Farmer, M.D.Lela A. Lee, M.D.Henry W. Lim, M.D.Paul I. Schneiderman, M.D.Elaine C. Siegfried, M.D.Kim B. Yancey, M.D.Daniel A. Davis, M.D.*Janet A. Fairley, M.D.*Jennifer L. Hand, M.D.*Donald L. Levin, M.D.*Stanley J. Miller, M.D. *Stephen B. Webster, M.D. (Staff)

26

Test Committee for Examination in Clinical and LaboratoryDermatology (Part IIA&B)

Leonard M. Dzubow, M.D., ChairmanRandall K. Roenigk, M.D., Vice ChairmanTerry L. Barrett, M.D.Robert T. Brodell, M.D.Jeffrey P. Callen, M.D.Ilona J. Frieden, M.D.Clifton R. White, Jr., M.D.David R. Adams, M.D.*Charles Camisa, M.D.*Lawrence F. Eichenfield, M.D.*Naomi Lawrence, M.D.*Jeffrey J.Miller, M.D.*Christen Mowad, M.D.*Clark C. Otley, M.D.*Robert A. Weiss, M.D.*Antoinette F. Hood, M.D. (Staff)

Test Committee for Examination in Dermatopathology

(Part IIC)Clifton R. White, Jr., M.D., ChairmanEvan R. Farmer, M.D., Vice ChairmanTerry L. Barrett, M.D.Thomas D. Horn, M.D.Marsha L. Chaffins, M.D.*Anita C. Gilliam, M.D.*Mary S. Stone, M.D.*Antoinette F. Hood, M.D. (Staff)

*Non-ABD Director members of the Test Committee.

RECERTIFICATION/

MAINTENANCE OF CERTIFICATION

Information about Recertification/Maintenance ofCertification may be found in a separate ABDbooklet entitled “Recertification/Maintenance ofCertification”, copies of which may be requestedfrom the Board office. Information may also bedownloaded from the ABD website atwww.abderm.org.

27

FELLOWSHIPS WITH

SUBSPECIALTY CERTIFICATION

The American Board of Dermatology hasestablished certification processes for thesubspecialties of Dermatopathology, Clinical andLaboratory Dermatological Immunology, andPediatric Dermatology. These subspecialtycertifications have been approved by the AmericanBoard of Medical Specialties and its 24 memberboards. Surveillance and periodic reviews of thetraining programs are carried out by the respectiveRRCs (Dermatopathology) under the auspices of theACGME, and/or by the ABD (Clinical and LaboratoryDermatological Immunology, and PediatricDermatology). Although all general dermatologyresidents receive comprehensive training in each ofthese subspecialties, candidates who pursue theadditional year(s) of training in subspecialtyfellowships will have met additional standards andqualifications that will prepare them for specializedcareers in teaching, research, and/or the practice ofthese subspecialties. It is emphasized also thatthe additional year(s) of training in Clinical andLaboratory Dermatological Immunology andPediatric Dermatology must be taken after thecandidate has met the full training requirementsfor certification in the primary specialty ofDermatology. Similarly, the additional year(s) oftraining in Dermatopathology must be takenafter the candidate has met the full trainingrequirements for certification in the primaryspecialty of Dermatology or Pathology.

CERTIFICATION IN

DERMATOPATHOLOGY

Subspecialty certification in Dermatopathology isa joint and equal function of the American Board ofDermatology (ABD) and the American Board ofPathology (ABP). Such function will relate toqualifications of candidates, standards ofexamination, and the form of the certificate.

All candidates applying to sit for this certifyingexamination must hold a currently valid, full andunrestricted license to practice medicine or

28

osteopathy in the state or province of his/herresidence in either the United States or Canada.The candidate may be denied certification if his/herlicensure has been revoked, suspended, restricted,or surrendered in any jurisdiction – or if thecandidate is subject to adverse licensureproceedings.

All candidates for this certification must satisfythe following requirements:

A. Prerequisites(1) Primary certification by both the American

Board of Dermatology and the American Board ofPathology (anatomic pathology or anatomic andclinical pathology).

OR (2) Primary certification by either the AmericanBoard of Dermatology or the American Board ofPathology (anatomic pathology or anatomic andclinical pathology), and the satisfactory completionof one year of training in dermatopathology in aprogram accredited for such training (see below) bythe ACGME. The dermatologist applicant mustspend one-half of the required training time inpathology. The pathologist applicant must spendone-half of the required training time in clinicaldermatology.

B. TrainingAccredited institutional training programs in

dermatopathology are an equal and joint function ofthe Departments of Dermatology and Pathology ofthat institution. Training programs in dermato-pathology are reviewed and accredited by theResidency Review Subcommittee for Dermato-pathology, which includes three members from theResidency Review Committee for Dermatology andthree members from the Residency ReviewCommittee for Pathology. Upon recommendation bythis subcommittee, training programs in dermato-pathology are accredited by conjoint action of theResidency Review Committees for Dermatology andPathology acting with authority delegated by theAccreditation Council for Graduate MedicalEducation (ACGME). Information concerningaccredited dermatopathology training programs maybe found in the AMA Graduate Medical Education

29

Directory (which is published annually) or on theACGME website at www.acgme.org. A preliminaryregistration form must be filed with the Board byeach trainee as explained on page 8.

C. Examination - Deadline for Application and Date of ExaminationCandidates who have satisfied the above

requirements are eligible to apply to the Board totake the examination for subspecialty certification inDermatopathology, which is a comprehensiveassessment of the candidates' knowledge ofdermatopathology, including the related basicsciences, and laboratory and clinical areaspertaining to this discipline.

Dermatologist candidates planning to take thesubspecialty certification examination shouldrequest an application from the office of theExecutive Director of the American Board ofDermatology. The deadline for receipt ofapplications is May 1 of the year in which thecandidate plans to take the examination. The nextexamination will be given on Thursday,September 15, 2005 in Tampa, Florida.

D. CertificateBeginning in 2006, Dermatopathology

certificates will have a 10-year time limit.

E. Appeals ProcessAn appeals procedure similar to that described

for the certification process in dermatology (Reviewof Adverse Decisions, pages 23-25) is available forcandidates for subspecialty certification inDermatopathology who were declared ineligible bythe Board for Dermatopathology or who failed theDermatopathology examination. Candidatessubmitting such appeals should contact the Boardfor additional current information.

JOINT POLICY COMMITTEEFOR DERMATOPATHOLOGY

Clifton R. White, Jr, M.D., Chairman (ABD)Robert W. McKenna, M.D., Vice Chairman (ABP)Terry L. Barrett, M.D. (ABD)John V. Collin, M.D. (ABP)Evan R. Farmer, M.D. (ABD)Sharon A. Weiss, M.D. (ABP)Betsy D. Bennett, M.D. (ABP Staff)Antoinette F. Hood, M.D. (ABD Staff)

30

DERMATOPATHOLOGY TEST DEVELOPMENTAND ADVISORY COMMITTEE

Terry L. Barrett, M.D., Co-Chairman (ABD)Sharon A. Weiss, M.D., Co-Chairman (ABP)Marsha L. Chaffins, M.D.* (ABD)Evan R. Farmer, M.D. (ABD)Anita C. Gilliam, M.D.* (ABD)Earl J. Glusac, M.D.* (ABP)Sabine S. Kohler, M.D.* (ABP)Glynis A. Scott, M.D.* (ABP)Mary S. Stone, M.D.* (ABD)Clifton R. White, Jr., M.D. (ABD)Betsy D. Bennett, M.D. (ABP Staff)Antoinette F. Hood, M.D. (ABD Staff)

*Non-ABD or non-ABP Director member of the Test Committee.

CERTIFICATION IN

CLINICAL AND LABORATORYDERMATOLOGICAL IMMUNOLOGY

The requirements for subspecialty certification inClinical and Laboratory Dermatological Immunologyare as follows:

A. Prerequisites(1) A currently valid, full and unrestricted

license to practice medicine or osteopathy in thestate or province of the candidate’s residence ineither the United States or Canada. The candidatemay be denied certification if his/her license hasbeen revoked, suspended, restricted, or surrenderedin any jurisdiction – or if the candidate is subject toadverse licensure proceedings.

(2) Primary certification by the American Boardof Dermatology followed by the satisfactorycompletion of at least one year of training in anaccredited fellowship in Clinical and LaboratoryDermatological Immunology.

B. TrainingInformation concerning accredited training

programs in Clinical and Laboratory DermatologicalImmunology is available from the office of theAmerican Board of Dermatology. As stated above,a minimum of one year of full-time training in aClinical and Laboratory Dermatological Immunologytraining program is required of all candidates. Apreliminary registration form must be filed with theBoard by each trainee as explained on page 8.

31

C. ExaminationCandidates who have satisfied the above

requirements are eligible to apply to take thesubspecialty certification examination in Clinical andLaboratory Dermatological Immunology.

D. Appeals ProcessAn appeals procedure similar to that described

for the certification process in dermatology (Reviewof Adverse Decisions, pages 23-25) is available forcandidates for subspecialty certification in Clinicaland Laboratory Dermatological Immunology whowere declared ineligible by the Board for Clinical andLaboratory Dermatological Immunology or whofailed the subspecialty examination. Candidatessubmitting such appeals should contact the Boardfor additional current information.

TEST COMMITTEE FOR CLINICAL AND LABORATORYDERMATOLOGICAL IMMUNOLOGY

Kim B. Yancey, M.D., ChairmanLela A. Lee, M.D.Antoinette F. Hood, M.D. (Staff)

CERTIFICATION IN

PEDIATRIC DERMATOLOGY

All candidates for subspecialty certification inPediatric Dermatology must meet the followingrequirements:

A. Prerequisites (1) A currently valid, full and unrestricted licenseto practice medicine or osteopathy in the state orprovince of the candidate’s residence in either theUnited States or Canada. The candidate may bedenied certification if his/her license has beenrevoked, suspended, restricted, or surrendered inany jurisdiction – or if the candidate is subject toadverse licensure proceedings.

(2) Primary certification by the American Boardof Dermatology (ABD).

B. Education, Training, ExperienceAdditional specific education and training or

experience that must be completed:

32

(1) One or more years of ACGME-approvedresidency training in pediatrics followed by therequisite training and certification in dermatologyand one additional final year of fellowship training inPediatric Dermatology.

OR (2) An ACGME-approved transitional year or anACGME-approved broad-based year of residencytraining in emergency medicine, family practice,general surgery, internal medicine, or obstetrics andgynecology, followed by the requisite training andcertification in dermatology. This track also requiresthe completion of a final two additional years offellowship training in Pediatric Dermatology.

OR (3) Special interest, experience, and expertise inPediatric Dermatology for at least five years. Thispathway will be open for only five years,commencing with the year of the first certifyingexamination (2004) in this subspecialty.

In the initial phase of certification in thissubspecialty, qualified practicing physicians will beeligible to apply for subspecialty certification with aminimum of 5 years of clinical practice in whichPediatric Dermatology comprises at least 50% of thetotal practice. Publications and invited lectures inPediatric Dermatology may also be submitted asdocumentation of special expertise. Individualsintending to sit for the certification examination usingthis pathway will be approved on a case-by-casebasis upon application to the ABD. Candidates whotrained in Pediatric Dermatology fellowships prior tothe development of approved fellowship trainingprograms will be permitted to sit for the certificationexamination after approval on a case-by-case basisupon application to the ABD.

The ABD wishes to emphasize that in thepathway described under (B2) above, sufficienteducation and experience in pediatrics (equivalentto six months of residency training in pediatrics) willbe required during the Pediatric Dermatologyfellowship. The entire curriculum outline forsubspecialty training in Pediatric Dermatology isavailable on the ABD website at www.abderm.org.

33

C. Examination – Deadline for Application andDate of Examination Candidates who have satisfied the aboverequirements are eligible to apply to the ABD to takethe subspecialty certification examination inPediatric Dermatology. Candidates planning to takethe subspecialty certification examination shouldrequest an application from the office of theAmerican Board of Dermatology. Applications mayalso be downloaded from the ABD website atwww.abderm.org. The deadline for receipt ofapplications is April 1 of the year in which thecandidate plans to take the examination. The nextexamination will be administered in 2006.

D. Certificate The Pediatric Dermatology certificate has a 10-year time limit.

E. Appeals Process An appeals procedure similar to that describedfor the certification process in dermatology (Reviewof Adverse Decisions, pages 23-25) is available forcandidates for subspecialty certification in PediatricDermatology who were declared ineligible by theBoard for Pediatric Dermatology or who failed thesubspecialty examination. Candidates submittingsuch appeals should contact the Board for additionalcurrent information.

TEST COMMITTEE FOR SUBSPECIALTY CERTIFICATION INPEDIATRIC DERMATOLOGY

Ilona J. Frieden, M.D., ChairmanElaine C. Siegfried, M.D., Vice ChairmanBernard Cohen, M.D.*Maria C. Garzon, M.D.*Fred E. Ghali, M.D.*Pearl C. Kwong, M.D.*Amy S. Paller, M.D.*Robert A. Silverman, M.D.*Michael L. Smith, M.D.*Mary Wu Chang, M.D.*Stephen B. Webster, M.D., Staff

*Non-ABD Director members of the Test Committee.

34

FELLOWSHIP WITHOUT CERTIFICATION

In 2003, a one-year PGY-5 level fellowshipprogram in Procedural Dermatology achievedaccreditation status by the ACGME. ProceduralDermatology includes dermatologic surgery whichmay be learned in an ACGME-accrediteddermatology residency training program. Thisfellowship program builds on the experience of adermatology resident and provides surgical trainingbeyond the scope which is expected in adermatology residency training program (PGY-2 toPGY-4). At the present time, a certificationexamination process in Procedural Dermatology hasnot been developed.

Procedural Dermatology is the subspecialtywithin Dermatology that is concerned with the study,diagnosis, and surgical treatment of diseases of theskin and adjacent mucous membranes, cutaneousappendages, hair, nails, and subcutaneous tissue.Dermatologic surgical procedures are minimallyinvasive and may be safely performed in outpatientsettings without general anesthesia or otherintravascular physiologic alteration. An especiallyimportant technique is Mohs micrographic surgicalexcision, which is used for certain cancers of theskin and incorporates training in clinical dermatologyand dermatopathology as they apply to dermatologicsurgery. In addition, cutaneous reconstruction ofsurgical defects, sclerotherapy, chemical peel, hairtransplantation, dermabrasion, small-volumeliposuction, cutaneous soft tissue augmentation withinjectable filler material, rhinophyma correction, andlaser surgery are important components of thesefellowships.

Procedural Dermatology fellowships areaccredited to offer 12 months of education andexperience subsequent to the satisfactorycompletion of an ACGME-accredited residency inDermatology, when all residents are required todevelop initial competence in dermatologic surgery.These fellowship programs in ProceduralDermatology provide an organized, systematic, andprogressive educational experience for physiciansseeking to acquire advanced competence as adermatologic surgeon.

35

The Procedural Dermatology fellowshipprograms provide organized education in all aspectsof procedural dermatology, including basic science,anatomy, anesthesia, ethics, pre- and post-operativemanagement, surgical technique, wound healing,Mohs micrographic surgery, laboratory technique,interpretation of pathologic specimens related toMohs micrographic surgery, cutaneousreconstruction or surgical defects, sclerotherapy,chemical peel, hair transplantation, dermabrasion,small-volume liposuction, cutaneous soft tissueaugmentation with injectable filler material,rhinophyma correction cutaneous oncology, lasersurgery, epidemiology, medicolegal and regulatoryissues, quality assurance, and self-assessment.

To view the Program Requirements for GraduateMedical Education in Procedural Dermatology andfor a list of accredited Procedural Dermatologyfellowship programs, go to the website of theAccreditation Council for Graduate MedicalEducation (www.acgme.org).

FEES

The Directors of the Board serve withoutcompensation. Fees are based on the actualexpenses incurred in administration of theBoard office and related activities, and on thecosts of development and administration of theBoard examinations.

All fees are payable when the application for anexamination is submitted and are applied to the firstexamination of that type given after approval of theapplication. Except as indicated below, or becauseof verifiable extenuating circumstances, there will beno refunds of any of these fees. The currentexamination fees are as follows:

Certifying Examination in Dermatology ....... $2,200.00Re-Examination in Dermatology .................. $2,100.00Subspecialty Certification Examination inDermatopathology ........................................ $1,800.00Subspecialty Certification Examination inClinical and LaboratoryDermatological Immunology......................... $1,000.00

36

Subspecialty Certification Examination inPediatric Dermatology .................................. $1,600.00Recertification Examination inDermatology..................................................... $900.00In-Training Examination .................................. $100.00

Other Fees:Rescoring of an examination..............................$35.00Request for verification of certification...............$35.00Checks returned for insufficient funds ...............$35.00

All checks are to be made payable to TheAmerican Board of Dermatology, Inc.® The Boardalso accepts credit card payments (VISA orMasterCard only). Contact the Board office fordetails.

When a candidate's application for the certifyingexamination in Dermatology or a subspecialtycertification examination is disapproved, the Boardretains an administrative fee of $150.00, and willrefund the balance to the candidate.

If a candidate withdraws within ten (10) days ofthe examination or fails to appear for the exam-ination and does not provide verifiable evidence ofextenuating circumstances that prevented him or herfrom appearing for the examination, the Board willretain the entire examination fee. On reapplying,such candidates will be required to again submit theexamination fee in effect at the time of theapplication. Candidates must notify the Board officein writing regarding all withdrawals fromexamination; a withdrawal will not be accepted bytelephone.

Candidates who fail the certifying examination inDermatology retain the right to apply to retake theexamination in subsequent years. For furtherinformation concerning Board policy in effect and forthe applicable examination fee, candidates areadvised to write or call the Board office (313-874-1088). Candidates who do not take the certifyingexamination at the first opportunity after completionof their training are also advised to contact theBoard office for clarification of Board policy and theexamination fee if they intend to apply to take thecertifying examination in any given year.

37

FUTURE EXAMINATION DATES AND SITES

In-Training Examination:April 21, 2005April 6, 2006

Certifying Examination:August 14 and 15, 2005 – Rosemont, IllinoisAugust 13 and 14, 2006 – Rosemont, Illinois

Recertification ExaminationAvailable online May 2 through June 16, 2005

Subspecialty Certification Examination inDermatopathology:

September 15, 2005 – Tampa, Florida

Subspecialty Certification Examination inPediatric Dermatology:

2006 (Date to be determined)

Subspecialty Certification Examination inClinical and Laboratory Dermatological

Immunology:No examination date determined

All correspondence should be sent to:

Antoinette F. Hood, M.D.Executive Director

American Board of Dermatology, Inc.Henry Ford Health System

1 Ford PlaceDetroit, Michigan 48202-3450

313-874-1088FAX:313-872-3221

E-mail:abderm@hfhs.org

38

INDEX

Appeals Procedures (Review of Adverse Decisions) -Certifying Examination ........................................ 23-25 -Dermatopathology.....................................................30 -Clin & Lab Dermatological Immunology ...................32 -Pediatric Dermatology...............................................34“Board-eligible”, use of term........................................17Candidates with Disabilities .................................. 20-21Certification............................................................ 21-22Chemical Dependency or Substance Abuse..............21Combined Training ................................................ 17-18Directors, Officers and Staff ..........................................2Directors, Emeritus and Consultants ........................ 3-4Examination, Board ............................................... 18-20 -Comprehensive Multiple Choice Exam .............. 18-19 -Date of Examination............................................ 20,38 -Deadline for Receipt of Applications.........................16 -Exam in Clinical & Lab Dermatology ........................19 -Exam in Dermatologic Surgery .................................19 -Exam in Dermatopathology.......................................19 -Re-Examination.........................................................20 -Registration for the Examination......................... 16-17 -Test Committees ................................................. 26-27Fees ....................................................................... 36-37Fellowship without Certification (Procedural Dermatology) ................................... 35-36Future Examination Dates and Sites ..........................38Guidelines for Determining Adequacy of Clinical Training .................................................. 14-15Historical Information.....................................................5In-Training Examination ........................................ 15-16Purposes and Functions of the Board ...................... 6-8Reapplication after Revocation of Certification................................................................26Recertification/Maintenance of Certification...............................................................27Requirements for Eligibility to Take the Certifying Examination in Dermatology .............. 10-14 -General Qualifications...............................................10 -Preliminary Registration Forms ............................ 8,13 -Residency Training Requirements ..................... 10-14 -Investigative/Academic Training Track............... 12-13 -Tabulation of Experience in Derm Surg. ..................13 -Yearly Evaluation Report Forms........................... 9,13Subspecialty Certification in Dermatopathology ............................................... 28-31 -Date of examination ............................................ 30,38 -Committees ......................................................... 30-31Subspecialty Certification in Clin & Lab Derm Immunology ............................................... 31-32-Test committee...........................................................32Subspecialty Certification in Ped Derm ................ 32-34 -Date of examination ............................................ 34,38 -Test committee..........................................................34Website & e-mail address .............................................1

IMPORTANT DATES FOR 2005

February 1: Receipt by Board office of applications for thein-training examination ($100.00 per resident).

March 1: Receipt by Board office of completed applicationfor the certifying examination of the American Board ofDermatology with accompanying fee of $2,200.00.Re-examination fee is $2,100.00. Requests for specialtesting circumstances (Americans with Disabilities Act) arealso due (see pages 20-21). Receipt also by Board officeof requests for approval of special investigative/academictraining tracks for residents (see pages 12-13).

April 21: Online In-Training examination.

May 1: Receipt by Board office of completed applicationfor subspecialty certification examination inDermatopathology with accompanying fee of $1,800.00.

May 2 to June 16: Online Recertification examination.(Refer to ABD Recertification/Maintenance of Certificationbooklet available online at www.abderm.org.)

May 15: Receipt by Board office of Third or Final YearEvaluation Report Forms for third/fourth year residentswho are completing their training on June 30, 2005 (yellowform), along with Tabulation of Experience inDermatologic Surgery forms (compilation of all three yearson one form).

August 1: Receipt by Board office of First and SecondYear Evaluation Report Forms (blue and pink forms), Listof Residents for 2005-2006 academic year, andPreliminary Registration Forms (green forms) for all firstyear residents.

August 14 and 15: ABD certification examination,Rosemont, Illinois.

September 15: Subspecialty certification examination inDermatopathology, Tampa, Florida.